NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Qritive

Qritive

Private
SingaporeHealthcare & Life Scienceshttps://www.qritive.com/

Last Round

Series A

Jan 9, 2023

Est. Valuation

$570,000

Total Funding Raised

$9.06M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Qritive is a healthcare technology company that provides an AI-powered platform to assist pathologists with cancer diagnosis.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, Computer Vision, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

digital pathologyAI pathologycancer diagnosticscomputational pathologypathology AIclinical decision supportwhole-slide imagingWSIbiomarker quantificationhistopathology workflowSaMDsoftware as a medical devicediagnostic automationpathology softwarehealthtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Qritive Comparables

Compare Qritive with similar companies based on industry and business-model similarity.

Qritive comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medmain inc.
88%
Onward Assist
84%
Franklin.ai
84%

Qritive Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 9, 2023
AcceleratorJan 19, 2018

Key People

Founding team and executive leadership

Bruno Occhipinti

Chief Executive Officer (CEO), Chief Commercial Officer (CCO)

Executive Team

Qritive Investors

Notable investors and investment history

Qritive investors
InvestorRounds
SEEDS CapitalSeries A
Pix Vine CapitalSeed
Exfinity Venture PartnersSeries A
MassMutual VenturesSeries A
Entrepreneurs FirstAccelerator
SGInnovateSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors grew 64% MoM, from 750 to 1.2K.

  • Aug 20, 2025

    Showcased technology at USCAP 2025 pathology conference.

Qritive Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Qritive Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Qritive's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore
Employee Range12
Year Founded2017
Last FundingJan 9, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.